KPTIQ

----

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Gainers

  • Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out today.
  • Burning Rock Biotech (NASDAQ:BNR) stock moved upwards by 19.45% to $14.8. The market value of their outstanding shares is at $130.6 million.
  • Skye Bioscience (NASDAQ:SKYE) shares moved upwards by 16.42% to $0.8. The market value of their outstanding shares is at $3.0 million.
  • Eikon Therapeutics (NASDAQ:EIKN) shares moved upwards by 15.84% to $6.8. The market value of their outstanding shares is at $317.9 million.
  • Harrow (NASDAQ:HROW) stock rose 15.61% to $31.76. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out yesterday.
  • Senseonics Holdings (NASDAQ:SENS) stock increased by 13.26% to $11.1. The market value of their outstanding shares is at $518.1 million. As per the news, the Q3 earnings report came out yesterday.

Losers

  • Karyopharm Therapeutics (NASDAQ:KPTI) stock decreased by 18.8% to $0.03 during Tuesday's pre-market session.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares declined by 12.86% to $2.17. The company's market cap stands at $2.7 million.
  • GeneDx Holdings (NASDAQ:WGS) shares fell 11.75% to $58.0. The company's market cap stands at $1.9 billion. As per the news, the Q3 earnings report came out yesterday.
  • Nordicus Partners (NASDAQ:NORD) stock fell 11.65% to $3.11. The company's market cap stands at $68.4 million.
  • Lakewood-Amedex (NASDAQ:LABT) stock decreased by 10.96% to $0.37.
  • Jade Biosciences (NASDAQ:JBIO) stock declined by 9.62% to $14.1. The company's market cap stands at $992.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock1,061characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.